Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Parasit Vectors ; 11(1): 598, 2018 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-30454052

RESUMEN

BACKGROUND: A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas was assessed in a randomized, controlled, 12-week study in client-owned cats in Germany and Spain. METHODS: Eligible households containing at least one cat with at least two fleas and/or two ticks were allocated randomly in a 2:1 ratio to a single treatment with fluralaner plus moxidectin on Day 0, or three 4-weekly treatments with fipronil (Frontline®). Veterinary staff, masked to treatment, completed tick and flea counts on each cat at 14 ± 2 (2 weeks), 28 ± 2 (4 weeks), 56 ± 2 (8 weeks) and 84 ± 2 days (12 weeks) after the initial treatment. RESULTS: In total, 707 cats (257 with ticks) from 332 households (236 with fleas) were included. Ixodes ricinus (78%) and Rhipicephalus sanguineus complex (18%) ticks were the most commonly identified. Tick and flea counts were lower in the fluralaner plus moxidectin group than in the fipronil group throughout the study and the efficacy of fluralaner plus moxidectin exceeded 97 and 98%, respectively. At 12 weeks, 94.1 and 93.3% of cats from the fluralaner plus moxidectin and 92.2 and 60.3% of cats from the fipronil group were free of ticks and fleas, respectively. Fluralaner plus moxidectin was non-inferior to fipronil (P < 0.0001) at all assessments and superior to fipronil at 2 and 8 weeks for the proportion of cats free of ticks (P < 0.0001). Fluralaner plus moxidectin was superior to fipronil for the proportion of both households and cats free of fleas (P < 0.0001). Both products were safe and well tolerated. CONCLUSIONS: A single application of fluralaner plus moxidectin spot-on was well tolerated by cats and highly effective for 12 weeks against ticks and fleas. Fluralaner plus moxidectin was non-inferior to fipronil for the proportion of ectoparasite-free and consistently superior to fipronil in controlling fleas.


Asunto(s)
Enfermedades de los Gatos/tratamiento farmacológico , Infestaciones por Pulgas/veterinaria , Insecticidas/uso terapéutico , Isoxazoles/uso terapéutico , Macrólidos/uso terapéutico , Infestaciones por Garrapatas/veterinaria , Administración Tópica , Animales , Enfermedades de los Gatos/epidemiología , Enfermedades de los Gatos/parasitología , Gatos , Infestaciones por Pulgas/tratamiento farmacológico , Infestaciones por Pulgas/epidemiología , Alemania/epidemiología , Insecticidas/administración & dosificación , Insecticidas/efectos adversos , Isoxazoles/administración & dosificación , Isoxazoles/efectos adversos , Ixodes/efectos de los fármacos , Macrólidos/administración & dosificación , Macrólidos/efectos adversos , Propiedad , Pirazoles/administración & dosificación , Pirazoles/uso terapéutico , Distribución Aleatoria , Rhipicephalus sanguineus/efectos de los fármacos , Método Simple Ciego , España/epidemiología , Infestaciones por Garrapatas/tratamiento farmacológico , Infestaciones por Garrapatas/epidemiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...